Maintaining serum phosphorus in the target range and its correlation with carotid atherosclerosis in maintenance hemodialysis patients with hyperphosphatemia

Bi-bo WU,Li-ming ZHANG,Qi TANG,Yun-lan HE,Yong YU,Xiao-ping HAO
DOI: https://doi.org/10.3969/j.issn.1671-4091.2015.08.007
2015-01-01
Abstract:Objective To investigate the achievement of serum phosphorus in the target range, and its correlation with carotid atherosclerosis (AS) in maintenance hemodialysis (MHD) patients with hyperphospha-temia and treated with phosphate binders. Methods We recruited 80 patients subjected to MHD for at least 3 months and with serum phosphorus >1.78 mmol/L. They were given one of the three phosphate binders for 2 years. Phosphate binder and its doses were adjusted to obtain serum phosphorus in target range. Serum phos-phorus, calcium and intact parathyroid hormone (iPTH) were assayed every 6 months during the treatment pe-riod. Carotid ultrasonography was performed to detect AS. After the therapy for 2 years, the patients were di-vided into high serum phosphorus group (≥1.78 mmol/L, n=50) and normal serum phosphorus group (<1.78 mmol/L, n=30). Results After the treatment for 6 months, serum phosphorus and iPTH decreased signifi-cantly and serum calcium increased significantly in all patients as compared with these parameters before treatment (P<0.05 or <0.01). Serum phosphorus and iPTH decreased gradually with the duration of phos-phate binder therapy. Serum phosphorus and iPTH, carotid intimal medial thickness (IMT), and the preva-lence of AS were lower in normal serum phosphorus group than in high serum phosphorus group (P<0.05 or <0.01). Serum phosphorus was positively correlated with the levels iPTH and IMT and the prevalence of AS in all MHD patients with hyperphosphatemia (P<0.05 or <0.01). A negative correlation was found be- <br> tween serum levels of phosphorus and calcium (P<0.05). Conclusion Hyperphosphatemia is a significant and independent risk factor of the advanced arteriosclerosis in MHD patients. Maintaining serum phosphorus concentration in the target range is effective to decrease the prevalence of AS in MHD patients.
What problem does this paper attempt to address?